239 related articles for article (PubMed ID: 26372034)
1. Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review.
Depmann M; Broer SL; van der Schouw YT; Tehrani FR; Eijkemans MJ; Mol BW; Broekmans FJ
Menopause; 2016 Feb; 23(2):224-32. PubMed ID: 26372034
[TBL] [Abstract][Full Text] [Related]
2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
[TBL] [Abstract][Full Text] [Related]
4. Anti-Mullerian hormone - a marker of upcoming menopause or a questionable guesswork?
Warzecha D; Szymusik I; Pietrzak B; Wielgos M
Neuro Endocrinol Lett; 2017 May; 38(2):75-82. PubMed ID: 28650599
[TBL] [Abstract][Full Text] [Related]
5. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
[TBL] [Abstract][Full Text] [Related]
6. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
[TBL] [Abstract][Full Text] [Related]
7. Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response.
Iliodromiti S; Anderson RA; Nelson SM
Hum Reprod Update; 2015; 21(6):698-710. PubMed ID: 25489055
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
10. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
Nelson SM; Klein BM; Arce JC
Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
[TBL] [Abstract][Full Text] [Related]
12. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone.
Fleming R; Seifer DB; Frattarelli JL; Ruman J
Reprod Biomed Online; 2015 Oct; 31(4):486-96. PubMed ID: 26283017
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.
Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F
J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134
[TBL] [Abstract][Full Text] [Related]
14. Role of AMH in Prediction of Menopause.
de Kat AC; Broekmans FJM; Lambalk CB
Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304
[TBL] [Abstract][Full Text] [Related]
15. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth.
Nelson SM; Fleming R; Gaudoin M; Choi B; Santo-Domingo K; Yao M
Fertil Steril; 2015 Aug; 104(2):325-32. PubMed ID: 26003269
[TBL] [Abstract][Full Text] [Related]
16. Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages.
Grande M; Borobio V; Bennasar M; Stergiotou I; Mercadé I; Masoller N; Peñarrubia J; Borrell A
Fertil Steril; 2015 May; 103(5):1221-7.e2. PubMed ID: 25796318
[TBL] [Abstract][Full Text] [Related]
17. Menopause prediction and potential implications.
Daan NM; Fauser BC
Maturitas; 2015 Nov; 82(3):257-65. PubMed ID: 26278873
[TBL] [Abstract][Full Text] [Related]
18. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
Tremellen K; Zander-Fox D
Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
Moolhuijsen LME; Visser JA
J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
